» Articles » PMID: 11431356

Identification of Gene Expression Profiles That Predict the Aggressive Behavior of Breast Cancer Cells

Overview
Journal Cancer Res
Specialty Oncology
Date 2001 Jun 30
PMID 11431356
Citations 103
Authors
Affiliations
Soon will be listed here.
Abstract

With the goal of identifying genes that have an expression pattern that can facilitate the diagnosis of primary breast cancers (BCs) as well as the discovery of novel drug leads for BC treatment, we used cDNA hybridization arrays to analyze the gene expression profiles (GEPs) of nine weakly invasive and four highly invasive BC cell lines. Differences in gene expression between weakly and highly invasive BC cells were identified that enabled the definition of consensus GEPs for each invasive phenotype. To determine whether the consensus GEPs, comprising 24 genes, could be used to predict the aggressiveness of previously uncharacterized cells, gene expression levels and comparative invasive and migratory characteristics of nine additional human mammary epithelial cell strains/lines were determined. The results demonstrated that the GEP of a cell line is predictive of its invasive and migratory behavior, as manifest by the morphology of its colonies when cultured on a matrix of basement membrane constituents (i.e., Matrigel). We found that the expression of keratin 19 was consistently elevated in the less aggressive BC cell lines and that vimentin and fos-related antigen-1 (FRA-1) were consistently overexpressed in the more highly aggressive BC cells. Moreover, even without these three genes, the GEP of a cell line still accurately predicted the aggressiveness of the BC cell, indicating that the expression pattern of multiple genes may be used as BC prognosticators because single markers often fail to be predictive in clinical specimens.

Citing Articles

FOSL1 is a key regulator of a super-enhancer driving TCOF1 expression in triple-negative breast cancer.

He Q, Hu J, Huang H, Wu T, Li W, Ramakrishnan S Epigenetics Chromatin. 2024; 17(1):34.

PMID: 39523372 PMC: 11552368. DOI: 10.1186/s13072-024-00559-1.


Targeting PRSS23 with tipranavir induces gastric cancer stem cell apoptosis and inhibits growth of gastric cancer via the MKK3/p38 MAPK-IL24 pathway.

Xiong J, Li Y, Tan X, Chen T, Liu B, Fu L Acta Pharmacol Sin. 2023; 45(2):405-421.

PMID: 37814123 PMC: 10789761. DOI: 10.1038/s41401-023-01165-9.


Quantitative dynamic contrast-enhance MRI parameters for rectal carcinoma characterization: correlation with tumor tissue composition.

Yuan J, Liu K, Zhang Y, Yang Y, Xu H, Han G World J Surg Oncol. 2023; 21(1):306.

PMID: 37749564 PMC: 10521534. DOI: 10.1186/s12957-023-03193-5.


The effect of the anti-leukemia inhibitory factor on the immune system in the Balb/c mice bearing breast cancer induced with 4T1 cells.

Yavari A, Zare F, Hadinedoushan H, Tahoori M Eur J Med Res. 2023; 28(1):211.

PMID: 37393300 PMC: 10314567. DOI: 10.1186/s40001-023-01196-2.


FRA-1 as a Regulator of EMT and Metastasis in Breast Cancer.

Casalino L, Talotta F, Matino I, Verde P Int J Mol Sci. 2023; 24(9).

PMID: 37176013 PMC: 10179602. DOI: 10.3390/ijms24098307.